دورية أكاديمية

The molecular characterization of colistin-resistant isolates of Acinetobacter baumannii from patients at intensive care units.

التفاصيل البيبلوغرافية
العنوان: The molecular characterization of colistin-resistant isolates of Acinetobacter baumannii from patients at intensive care units.
المؤلفون: Farajnia S; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Lotfi F; Department of Biological Sciences, Faculty of Basic Sciences, Higher Education Institute of Rab-Rashid, Tabriz, Iran., Dehnad A; Department of Biotechnology, East Azerbaijan Research and Education Center Agricultural and Natural Resources, Razi Vaccine and Serum Research Institute, AREEO, Tabriz, Iran., Shojaie M; Department of Biological Sciences, Faculty of Basic Sciences, Higher Education Institute of Rab-Rashid, Tabriz, Iran., Raisi R; Department of Biological Sciences, Faculty of Basic Sciences, Higher Education Institute of Rab-Rashid, Tabriz, Iran., Rahbarnia L; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Bazmani A; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Naghili B; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Shiry S; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
المصدر: Iranian journal of microbiology [Iran J Microbiol] 2022 Jun; Vol. 14 (3), pp. 319-327.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Tehran University of Medical Sciences Country of Publication: Iran NLM ID: 101518404 Publication Model: Print Cited Medium: Print ISSN: 2008-3289 (Print) Linking ISSN: 20083289 NLM ISO Abbreviation: Iran J Microbiol Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Tehran : Tehran University of Medical Sciences
مستخلص: Background and Objectives: The objective of this study was to determine molecular characterization and genetic diversity of colistin-resistant A. baumannii clinical isolates in Intensive Care Unit hospitalized patients.
Materials and Methods: A total of 127 A. baumannii clinical isolates were evaluated for antimicrobial susceptibility. PCR reaction and sequencing were performed for the detection of mutations in pmrAB and lpx ACD genes.
Results: Based on antimicrobial susceptibility testing, 40.94% and 33.85% of the isolates were MDR and XDR respectively whereas 3.93% of them were found to be PDR. Results of agar dilution MIC and E-test indicated that 76% of the isolates were sensitive to colistin. All of the isolates were positive for bla OXA-51 and 50% of them were positive for both bla OXA-23 -like and bla OXA-143 -like genes while only 25% of the isolates were positive for bla OXA-72 . None of them were positive for the bla OXA-58 -like gene. There is no mutation in pmrA . The V162A substitution for pmrB gene was repeated in two isolates, and E 394 D and Y 292 H substitutions in lpxA were observed in two isolates; also, C 120 R and F 165 L substitutions in lpxC gene was repeated in two isolates. Analysis of phylogenetic tree based on alterations in lpxACD and pmrB genes indicated the appearance of new isolates compared to the reference strain ATCC17978 A. baumannii isolates.
Conclusion: The present study indicated the prevalence of MDR and XDR A. baumannii isolates and the emergence of PDR isolates in the northwest portion of Iran. The appearance of colistin-resistant isolates with new mutations in pmrB, lpxACD genes indicates new resistance mechanisms.
(Copyright © 2022 The Authors. Published by Tehran University of Medical Sciences.)
References: Int J Antimicrob Agents. 2012 Jun;39(6):526-8. (PMID: 22521767)
Antimicrob Resist Infect Control. 2019 Nov 7;8:172. (PMID: 31719975)
Med J Islam Repub Iran. 2020 Mar 23;34:24. (PMID: 32551313)
Clin Microbiol Rev. 2008 Jul;21(3):538-82. (PMID: 18625687)
Antimicrob Agents Chemother. 2009 Sep;53(9):3628-34. (PMID: 19528270)
Antimicrob Agents Chemother. 2010 Dec;54(12):4971-7. (PMID: 20855724)
Microb Drug Resist. 2018 May;24(4):359-366. (PMID: 28972863)
Front Microbiol. 2019 Jan 04;9:2898. (PMID: 30662431)
Antimicrob Agents Chemother. 2011 Jul;55(7):3370-9. (PMID: 21576434)
Sci Rep. 2016 Jun 22;6:28291. (PMID: 27329501)
Microb Drug Resist. 2018 Jun;24(5):675-679. (PMID: 29053085)
Int J Antimicrob Agents. 2011 Jun;37(6):525-30. (PMID: 21497062)
Antibiotics (Basel). 2017 Nov 21;6(4):. (PMID: 29160808)
Biomed Res Int. 2017;2017:7157923. (PMID: 28804720)
J Microbiol. 2015 Jan;53(1):53-9. (PMID: 25557480)
Microb Drug Resist. 2019 Sep;25(7):997-1002. (PMID: 30964377)
Int J Antimicrob Agents. 2017 Jun;49(6):727-733. (PMID: 28438568)
Clin Microbiol Infect. 2016 Apr;22(4):352-358. (PMID: 26711434)
Antimicrob Agents Chemother. 2011 Jun;55(6):3022-4. (PMID: 21402838)
Clin Microbiol Infect. 2012 Mar;18(3):268-81. (PMID: 21793988)
J Lab Physicians. 2018 Jul-Sep;10(3):289-293. (PMID: 30078964)
Expert Rev Anti Infect Ther. 2013 Apr;11(4):383-93. (PMID: 23566148)
Microb Drug Resist. 2018 Nov;24(9):1271-1276. (PMID: 29590004)
BMC Res Notes. 2019 May 10;12(1):260. (PMID: 31077228)
Future Microbiol. 2008 Dec;3(6):649-60. (PMID: 19072182)
BMC Res Notes. 2020 Aug 10;13(1):380. (PMID: 32778154)
J Clin Microbiol. 2009 Feb;47(2):294-9. (PMID: 19036936)
J Clin Microbiol. 2004 Mar;42(3):946-53. (PMID: 15004037)
Expert Rev Anti Infect Ther. 2012 Aug;10(8):917-34. (PMID: 23030331)
BMC Infect Dis. 2020 Aug 12;20(1):597. (PMID: 32787942)
Expert Opin Pharmacother. 2012 Nov;13(16):2319-36. (PMID: 23035697)
فهرسة مساهمة: Keywords: Acinetobacter baumannii; Beta-lactamase OXA-143; Beta-lactamase OXA-23; Beta-lactamase OXA-58; Colistin; OXA-72 carbapenemase
تواريخ الأحداث: Date Created: 20230501 Latest Revision: 20230502
رمز التحديث: 20230502
مُعرف محوري في PubMed: PMC10132339
DOI: 10.18502/ijm.v14i3.9768
PMID: 37124847
قاعدة البيانات: MEDLINE